We have put in place stringent protocols to protect our staff from exposure to the Ebola virus and to monitor the health of returning staff. Read more about the protocols here.


We take a look at a simple and inexpensive treatments initiative, which aims to improve HIV patients' access to care in rural Zimbabwe.


Amidst all the loss and suffering, there are several stories of survival. Today, out of all the patients cared for in MSF’s projects in Guinea, Sierra Leone and Liberia, we celebrate the one thousandth survivor.

MSF doctor Silje Lehne Michalsen has now recovered after contracting Ebola. This picture of Silje was taken in MSF's hospital in Bo, Sierra Leone.

Silje contracted Ebola while working for MSF in Sierra Leone. She began to show symptoms on 4th October and was flown home to Norway. Today, she was discharged after recovering from the virus.


MSF has taken the very difficult decision to temporarily suspend medical activities at Gondama Referral Centre, near Bo, because of the strain the current response to the Ebola outbreak in West Africa has put on the organisation’s capacity in the country.


Since 4th October, bombing and shelling has intensified in the Erbin area near Damascus. The worst individual incident was the bombing of a market on 9th October which reported a mass-casualty influx of 250 wounded.


Salome Karwah is an Ebola survivor. After recovering from the virus she came back to work at the MSF treatment centre where she fought the disease. This is her story.


We take a look inside MSF's newest Ebola treatment centre in Bo, which just weeks after opening is already at full capacity. Three of the first patients to be discharged were siblings. Read their story.


Dr Bertrand Draguez is Médecins Sans Frontières/Doctors Without Borders (MSF)’s medical director currently working on the West Africa Ebola outbreak. Here he explains why developing vaccines and treatments for Ebola is important, what is needed in order for them to make an impact in this outbreak, and why MSF is taking exceptional measures in facilitating clinical trials for potential treatments.


The situation in Bangui, the capital of Central African Republic, has been extremely tense since a wave of violence broke out on 7th October.